Ultimate Biopharma Company
Ultimate Biopharma Company, often referred to as UBC, is a leading player in the biopharmaceutical industry, headquartered in China (CN). Established in 2005, the company has made significant strides in developing innovative therapies and solutions, primarily focusing on oncology, immunology, and rare diseases. With a strong presence in Asia and expanding operations in Europe and North America, UBC is renowned for its cutting-edge biologics and advanced drug delivery systems. The company’s commitment to research and development has led to several key milestones, including successful collaborations with global pharmaceutical firms. Ultimate Biopharma's unique product offerings, characterised by their efficacy and safety, have positioned it as a trusted name in the market, earning accolades for its contributions to patient care and therapeutic advancements.
DitchCarbon Score
How does Ultimate Biopharma Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ultimate Biopharma Company's score of 0 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ultimate Biopharma Company's reported carbon emissions
Ultimate Biopharma Company, headquartered in CN, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate pledges. This lack of publicly available information may suggest that Ultimate Biopharma Company is still in the early stages of developing a comprehensive climate strategy or reporting framework. As the biopharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Ultimate Biopharma to establish clear commitments and measurable targets to address their carbon footprint and contribute to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ultimate Biopharma Company is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
